INHALED VACCINE

Researchers at the Tulane National Primate Research Center found that an inhaled vaccine currently being developed induces a robust and long-lasting immune response against SARS-CoV-2 in nonhuman primates, similar to the protection provided by the Moderna vaccine.

Horizontal thumbnail